📷 Image: Wikimedia Commons / A.Savin
Business
Maharashtra FDA to Pay ₹5 Lakh After Bombay HC Orders Licence Suspension
✍️ Business Standard
🗓 18 Aug 2026, 01:04 PM
👁 6
The Maharashtra Food and Drug Administration will pay ₹5 lakh following a Bombay High Court ruling that suspended its licence.
The Bombay High Court has issued an order directing the Maharashtra Food and Drug Administration (FDA) to pay ₹5 lakh to a concerned party after suspending the agency’s licence. The court’s decision was based on procedural lapses in the licence renewal process. The FDA is required to comply with the payment within the stipulated time frame.
The suspension of the licence was imposed earlier this year when the court found that the FDA had not adhered to statutory guidelines during the renewal. The order also mandates that the agency review its internal compliance mechanisms to prevent future violations.
Industry observers say the ruling underscores the importance of regulatory adherence for state agencies. The decision may prompt other state bodies to tighten their processes to avoid similar legal challenges.
The Maharashtra government has not yet released a statement on the court’s directive, but it is expected to cooperate with the FDA’s compliance measures.
The suspension of the licence was imposed earlier this year when the court found that the FDA had not adhered to statutory guidelines during the renewal. The order also mandates that the agency review its internal compliance mechanisms to prevent future violations.
Industry observers say the ruling underscores the importance of regulatory adherence for state agencies. The decision may prompt other state bodies to tighten their processes to avoid similar legal challenges.
The Maharashtra government has not yet released a statement on the court’s directive, but it is expected to cooperate with the FDA’s compliance measures.